Latigo Biotherapeutics develops non-opioid pain treatments, focusing on selective Nav1.8 inhibitors.

Eikon Therapeutics develops new medicines using advanced technologies like single-molecule tracking and high-performance computing to accelerate drug discovery and development.

Abcuro, Inc. is a biotechnology company developing therapies for autoimmune diseases and cancer, with a focus on their lead candidate, ulviprubart, a monoclonal antibody for treating inclusion body myositis.

Pleno, Inc. is a clinical and multi-omics diagnostics company focused on revolutionizing biological target detection with its RAPTOR™ multi-omic instrument platform.

Sollis Health provides 24/7 concierge medical services with a focus on high-touch member experiences and proprietary technology.

Avenzo Therapeutics is a biotechnology company developing oncology therapies, including a CDK2 inhibitor for advanced solid tumors and HR+/HER2-negative metastatic breast cancer.

Seaport Therapeutics develops neuropsychiatric medicines using its Glyph technology platform to enhance oral bioavailability and reduce side effects, with a focus on treating depression, anxiety, and other disorders.

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.